an increasing trendP < .06
Rosiglitazone treatment had no effect upon PPAR- γ protein, while SIRT1 protein was increased under 1% oxygen with Rosiglitazone ( Figure 6(f) ) and UCP-2 protein displayed an increasing trend ( P < .06).
Rosiglitazone treatment had no effect upon PPAR- γ protein, while SIRT1 protein was increased under 1% oxygen with Rosiglitazone ( Figure 6(f) ) and UCP-2 protein displayed an increasing trend ( P < .06).